JP2024525837A5 - - Google Patents

Info

Publication number
JP2024525837A5
JP2024525837A5 JP2024502210A JP2024502210A JP2024525837A5 JP 2024525837 A5 JP2024525837 A5 JP 2024525837A5 JP 2024502210 A JP2024502210 A JP 2024502210A JP 2024502210 A JP2024502210 A JP 2024502210A JP 2024525837 A5 JP2024525837 A5 JP 2024525837A5
Authority
JP
Japan
Prior art keywords
aso
seq
jak2
pharmaceutical composition
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024502210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525837A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073668 external-priority patent/WO2023288240A1/en
Publication of JP2024525837A publication Critical patent/JP2024525837A/ja
Publication of JP2024525837A5 publication Critical patent/JP2024525837A5/ja
Pending legal-status Critical Current

Links

JP2024502210A 2021-07-15 2022-07-13 アンチセンスオリゴヌクレオチド（ａｓｏ）遺伝子阻害及び処置 Pending JP2024525837A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163222336P 2021-07-15 2021-07-15
US63/222,336 2021-07-15
US202163224362P 2021-07-21 2021-07-21
US63/224,362 2021-07-21
PCT/US2022/073668 WO2023288240A1 (en) 2021-07-15 2022-07-13 Antisense oligonucleotide (aso) gene inhibition and treatment

Publications (2)

Publication Number Publication Date
JP2024525837A JP2024525837A (ja) 2024-07-12
JP2024525837A5 true JP2024525837A5 (https=) 2025-06-23

Family

ID=82850241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502210A Pending JP2024525837A (ja) 2021-07-15 2022-07-13 アンチセンスオリゴヌクレオチド（ａｓｏ）遺伝子阻害及び処置

Country Status (8)

Country Link
EP (1) EP4370133A1 (https=)
JP (1) JP2024525837A (https=)
KR (1) KR20240037996A (https=)
AU (1) AU2022312494A1 (https=)
CA (1) CA3224471A1 (https=)
IL (1) IL309813A (https=)
MX (1) MX2024000636A (https=)
WO (1) WO2023288240A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121039279A (zh) * 2023-05-05 2025-11-28 万达制药公司 反义寡核苷酸(aso)基因抑制和治疗

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014161046A1 (en) * 2013-04-04 2014-10-09 The Walter And Eliza Hall Institute Of Medical Research Methods of treating diseases characterized by excessive wnt signalling
WO2017214463A1 (en) * 2016-06-09 2017-12-14 The Regents Of The University Of California Compositions and methods for treating cancer and biomarkers to detect cancer stem cell reprogramming and progression

Similar Documents

Publication Publication Date Title
JP7625637B2 (ja) Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬
JP7763907B2 (ja) Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬
US20130177624A1 (en) Mirna expression in allergic disease
CA2081777A1 (en) Inhibition of influenza virus replication by oligonucleotides
JP2005503142A5 (https=)
EP3790971A1 (en) Oligonucleotides for modulating myh7 expression
WO2023098908A1 (en) Modification patterns for small interfering rna molecules with high stability and gene silencing activities
JP2021511072A5 (https=)
US11781140B2 (en) Antisense nucleic acid inducing skipping of exon 51
CN118109468A (zh) 诱导外显子50的跳读的反义核酸
JP2024525837A5 (https=)
JP2021524277A (ja) Ｒｔｅｌ１発現の調節用のオリゴヌクレオチド
CN115702006A (zh) 缀合基团及其缀合物
JP2024543952A5 (https=)
JP2024522147A5 (https=)
RU2024103101A (ru) Ингибирование гена антисмысловым олигонуклеотидом (аso) и лечение
JP2024529930A (ja) 低減されたオフターゲット効果を有する修飾低分子干渉ｒｎａ分子
KR20240037996A (ko) 안티센스 올리고뉴클레오티드 (aso) 유전자 억제 및 치료
JP7813254B2 (ja) Ｆｕｂｐ１発現を調節するための増強されたオリゴヌクレオチド
JP2025522625A5 (https=)
HK40097454A (zh) 用於b型肝炎病毒感染的rnai剂
WO2025252063A1 (zh) 靶向pnpla3的双链核糖核酸
TW202604552A (zh) 用於降低atxn3表達之修飾寡核苷酸
WO2025252669A1 (en) Modified oligonucleotides for reducing atxn3 expression
TW202613311A (zh) 靶向pnpla3的雙鏈核糖核酸